ALS One is a nonprofit organization dedicated to accelerating the development of treatments and a cure for Amyotrophic Lateral Sclerosis (ALS) by funding collaborative research, supporting patient care initiatives, and raising public awareness about the disease.
Biomedical research funding, federal investment in ALS research, expanded access to experimental treatments, patient support services, and policies that accelerate drug development and regulatory approval for neurodegenerative diseases.
Individual donations, foundation grants, corporate sponsorships, and fundraising events.
ALS researchers and clinicians from leading academic medical centers, ALS patient advocacy groups, and philanthropic partners supporting neurodegenerative disease research.
Non-profit organization
